Eli Lilly & Co. urged doctors to prescribe Zyprexa for elderly patients with dementia, an unapproved use for the antipsychotic, even though the drugmaker had evidence the medicine didn't work for such patients, according to unsealed internal company documents.
In 1999, four years after Lilly sent study results to the U.S. Food and Drug Administration showing Zyprexa didn't alleviate dementia symptoms in older patients, it began marketing the drug to those very people, according to documents unsealed in insurer suits against the company for overpayment.
Regulators required Lilly and other antipsychotic drug- makers in April 2005 to warn that the products posed an increased risk to elderly patients with dementia. The documents show the health dangers in marketing a drug for an unapproved use, called off-label promotion, said Sidney Wolfe, head of the health research group at Public Citizen in Washington.
Wolfe: "By definition, off-label means there is no clear evidence that the benefits of a drug outweigh the risks. The reason why off-label promotion is illegal is that you can greatly magnify the number of people who will be harmed."
Full Article and Source:
Lilly Sold Drug for Dementia Knowing It Didn’t Help, Files Show
See also:
Bitter Pill
In 1999, four years after Lilly sent study results to the U.S. Food and Drug Administration showing Zyprexa didn't alleviate dementia symptoms in older patients, it began marketing the drug to those very people, according to documents unsealed in insurer suits against the company for overpayment.
Regulators required Lilly and other antipsychotic drug- makers in April 2005 to warn that the products posed an increased risk to elderly patients with dementia. The documents show the health dangers in marketing a drug for an unapproved use, called off-label promotion, said Sidney Wolfe, head of the health research group at Public Citizen in Washington.
Wolfe: "By definition, off-label means there is no clear evidence that the benefits of a drug outweigh the risks. The reason why off-label promotion is illegal is that you can greatly magnify the number of people who will be harmed."
Full Article and Source:
Lilly Sold Drug for Dementia Knowing It Didn’t Help, Files Show
See also:
Bitter Pill
3 comments:
Big pharma = big money.
It's all about money.
Big Pharma knows the fines for misbehaving are nothing compared to the profits.
Damn hungry bastards!
Post a Comment